Target intelligence / Profile preview

Alpha-1 antitrypsin (SERPINA1) E342K mutant allele (SERPINA1 E342K)

Target
SERPINA1 E342K
Molecular classification
Gene, Serine protease inhibitor family
01

Overview

The SERPINA1 E342K mutant allele, commonly known as the PiZ allele, is the primary genetic cause of severe Alpha-1 Antitrypsin Deficiency (AATD). This single nucleotide polymorphism (G>A) results in a glutamic acid to lysine substitution at position 342, leading to the misfolding and polymerization of the alpha-1 antitrypsin (AAT) protein within the endoplasmic reticulum of hepatocytes. This process causes a dual pathology: liver injury due to the toxic accumulation of protein polymers and lung disease (emphysema) due to the lack of circulating AAT to protect lung tissue from proteolytic enzymes like neutrophil elastase. Targeting the mutant allele in hepatocyte genomic DNA using gene editing technologies, such as base editing or CRISPR/Cas9, aims to permanently correct the mutation. This approach is designed to restore the secretion of functional, monomeric AAT into the bloodstream while simultaneously halting the production of hepatotoxic polymers.

Other names
PiZ alleleZ mutationSERPINA1 Z variantrs28929474Alpha-1 antitrypsin Z allele
02

Mechanism of action

Direct correction of the G-to-A point mutation at the genomic level using base editing or gene replacement to restore production of functional alpha-1 antitrypsin and reduce toxic polymer accumulation.

03

Biological functions

Protease inhibitionProtein foldingHomeostasis of lung elastase
04

Disease associations

Alpha-1 antitrypsin deficiencyLiver cirrhosisHepatocellular carcinomaPulmonary emphysema
05

Safety considerations

Off-target genomic editingUnintended insertions or deletions (indels)Immune response to Cas9 or delivery vectorsLong-term effects of permanent genomic modification
06

Interacting drugs

BEAM-302

1 more in the full profile.

07

Biomarkers

Serum alpha-1 antitrypsin levelsIntrahepatic Z-AAT polymer levelsAlanine aminotransferase (ALT)Aspartate aminotransferase (AST)Liver stiffness (FibroScan)

Beyond the preview

Go deeper on Alpha-1 antitrypsin (SERPINA1) E342K mutant allele (SERPINA1 E342K).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1 antitrypsin (SERPINA1) E342K mutant allele (SERPINA1 E342K).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call